Physicians

David Charles, MD | Arturo Loaiza-Bonilla, MD | Anthony D Woolf, FRCP

 

David Charles, MD

Dr. David Charles is Chairman of the Alliance for Patient Access and a practicing neurologist in Nashville, Tennessee.  Dr. Charles is a national leader in movement disorders research and is past chairman of the Public Policy Committee for the American Neurological Association and Legislative Affairs committee of the American Academy of Neurology. He is a fellow of the American Academy of Neurology and American Neurological Association and past Board member of the United Council of Neurologic Subspecialties, and Past-President of the Tennessee Academy of Neurology. He is currently leading the only clinical trial approved by the United States Food and Drug Administration to test deep brain stimulation in people with early stage Parkinson’s disease. Dr. Charles took leave from his practice in 1998 and spent a year on the staff of the U.S. Senate Subcommittee for Public Health and Safety, where he served as a health policy advisor. Following this experience in Washington, Dr. Charles conducted Parkinson’s disease research in France as a Fulbright Senior Scholar.

Arturo Loaiza-Bonilla, MD


Dr. Loaiza-Bonilla is the current Vice President of Medical Oncology at the Cancer Treatment Centers of America and head of clinical research. He is an expert speaker who served as Assistant Professor in Hematology / Oncology at the Abramson Cancer Center of the University of Pennsylvania, and educated at the University of Miami, Johns Hopkins and the NIH. Dr. Loaiza-Bonilla specializes in clinical trials and translational research, as well as multidisciplinary comprehensive care of patients suffering from gastrointestinal cancers, and is an expert in the integration of personalized cancer genomics, biosimilars, pharmacoeconomics technology, artificial intelligence, the use of immunotherapy and targeted therapies. Dr. Loaiza-Bonilla is a passionate advocate of oncology precision, medical education, leadership of organized medicine and health policy. Dr. Loaiza-Bonilla was awarded the Leadership Award Foundation Fellowship the American Medical Association (AMA) and the American College of Physicians (ACP), and listed as Castle Connolly Top Doctor and selected as one of Pennsylvania Magazine’s 2019 Top Doctors. In addition, he has a Master ‘s degree in Medical Education (MSEd) degree from the University of Pennsylvania and serves as the President Elect of the Pennsylvania ASCO State Affiliate (PSOH).

 

Anthony D Woolf, FRCP

Professor Anthony Woolf is Director, of the Bone and Joint Research Group, Royal Cornwall Hospital, Truro, UK and Chair, Arthritis and Musculoskeletal Alliance UK. He is a consultant rheumatologist and has held honorary chairs in Rheumatology at the University of Exeter Medical School, Plymouth University Peninsula Schools of Medicine and Dentistry, and visiting Professor in Musculoskeletal Science, Faculty of Medicine, Lund University, Sweden.  He was Clinical Director, National Institute of Health Research (NIHR) Clinical Research Network South West Peninsula until 2019.

His work focuses on influencing policy and practice nationally and internationally.  His academic activities focus on providing evidence to support the development and implementation of evidence-based health policy at a national, European and global level through leading the Bone and Joint Monitor Project, a global health needs assessment of musculoskeletal conditions undertaken through international collaborative activities, including the Global Burden of Disease study for which he co-leads the Musculoskeletal Expert Group.  He co-chaired WHO ICD Revision Musculoskeletal Topic Advisory Group and is now a member of the WHO Medical Scientific Advisory Committee for the International Classification of Diseases. His current focus is on the importance of musculoskeletal health in the workplace and in ageing populations and improving pathways of care. He has also focused on improving clinical competencies through teaching, writing and setting training standards at a national, European and international level. He has edited Best Practice and Research Clinical Rheumatology for over 20 years.

Dr. Woolf has held leading positions within various national, European and International organisations – Past Chair and founder member of the Global Alliance for Musculoskeletal Health; past member of EULAR Executive Committee as chair of the Education and Training Standing Committee and International Liaison Officer; and past President UEMS / European Board of Rheumatology.

He works with and advises policymakers in the European Commission and WHO on various relevant issues, in particular disability, ageing, and noncommunicable diseases.  He works with NHS England, Public Health England and Department of Work and Pensions to ensure musculoskeletal health is in all policies – health, social and employment.  He advised WHO Europe on including musculoskeletal health in the Noncommunicable Disease Action Plan 2016 – 2026 and WHO Geneva on the World Report on Ageing and Health. He is currently working with policy makers and employers in England to reduce the impact that musculoskeletal conditions have on people’s ability to work and in an ageing population.

 

Stay Informed View the latest newsletter

To receive regular newsletters and periodic alerts from the BPC, enter your email address in the form below:

(function($) {window.fnames = new Array(); window.ftypes = new Array();fnames[0]='EMAIL';ftypes[0]='email';fnames[1]='FNAME';ftypes[1]='text';fnames[2]='LNAME';ftypes[2]='text';}(jQuery));var $mcj = jQuery.noConflict(true);